North America Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)
The mid-size pharmaceutical market in North America is expected to grow from US$ 313,406.34 million in 2022 to US$ 461,269.34 million by 2028; it is estimated to grow at a CAGR of 6.7% from 2022 to 2028.
The rising prevalence of chronic disorders drives the growth of the North America mid-size pharmaceutical market. The aging population and changing lifestyle contribute to the steady increase in the incidence of common and costly long-term health problems. With the accelerating urbanization, people are adopting sedentary lifestyle, which boosts obesity and diabetes cases. According to the World Health Organization, the prevalence of chronic diseases is projected to increase by 57% by 2026 from the current situation. Many people in North America develop diabetes every year, causing life-changing complications. According to the International Diabetes Federation (IDF), the region reported about 46 million diabetes cases in 2019, which are projected to increase to 62 million by 2045. Increasing demand for health care systems due to the rising cases of chronic illnesses has become a major concern which is in turn boosting the mid-size pharmaceutical market in North America region.
By introducing new features and technologies, vendors in the North America mid-size pharmaceutical market can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the market growth at a good CAGR during the forecast period.
North America Mid-Size Pharmaceutical Market Revenue and Forecast to 2028 (US$ Million)
North America Mid-Size Pharmaceutical Market Segmentation
The North America mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.
Based on type, the North America mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share. Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022. Based on formulation, the North America mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022. Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022. Based on country, the North America mid-size pharmaceutical market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2022.
Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Eisai Co., Ltd.; Endo Pharmaceuticals Inc.; Mallinckrodt; Regeneron Pharmaceuticals, Inc; and Sun Pharmaceutical Industries Ltd are among the leading companies operating in the mid-size pharmaceutical market in the region.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Mid-Size Pharmaceutical – By Type
1.3.2 North America Mid-Size Pharmaceutical – By Drug Development Type
1.3.3 North America Mid-Size Pharmaceutical – By Formulation
1.3.4 North America Mid-Size Pharmaceutical – By Therapy Area
1.3.5 North America Mid-Size Pharmaceutical – By Country
2. Mid-Size Pharmaceutical– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Mid-Size Pharmaceutical – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Disorders
5.1.2 Increasing Product Approval and Launches
5.2 Market Restraints
5.2.1 High Competition among Market Players
5.3 Market Opportunities
5.3.1 Rising Number of Healthcare Start-ups
5.4 Future Trends
5.4.1 Increasing Focus on R&D
5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market– North America Analysis
6.1 North America Mid-Size Pharmaceutical Market Revenue Forecast and Analysis
7. North America Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type
7.1 Overview
7.2 North America Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Over-the-Counter (OTC)
7.4.1 Overview
7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Mid-Size Pharmaceutical Market Analysis – By Drug Development Type
8.1 Overview
8.2 North America Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
8.3 In-House
8.3.1 Overview
8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Outsource
8.4.1 Overview
8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Mid-Size Pharmaceutical Market – By Formulation
9.1 Overview
9.2 North America Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
9.3 Tablets and Capsules
9.3.1 Overview
9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Injectables
9.4.1 Overview
9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Sprays
9.5.1 Overview
9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Other Formulations
9.6.1 Overview
9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Mid-Size Pharmaceutical Market – By Therapy Class
10.1 Overview
10.2 North America Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
10.3 Cardiovascular Diseases
10.3.1 Overview
10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Pain Management
10.4.1 Overview
10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Diabetes
10.5.1 Overview
10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Cancer
10.6.1 Overview
10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Other Diseases
10.7.1 Overview
10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11. North America Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Overview
11.1.2 North America: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
11.1.2.1 US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.1.1 Overview
11.1.2.1.2 US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.1.3 US: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)
11.1.2.1.4 US: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)
11.1.2.1.5 US: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)
11.1.2.1.6 US: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)
11.1.2.2 Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.2.1 Overview
11.1.2.2.2 Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.2.3 Canada: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)
11.1.2.2.4 Canada: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)
11.1.2.2.5 Canada: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)
11.1.2.2.6 Canada: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)
11.1.2.3 Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.3.1 Overview
11.1.2.3.2 Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.2.3.3 Mexico: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)
11.1.2.3.4 Mexico: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)
11.1.2.3.5 Mexico: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)
11.1.2.3.6 Mexico: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)
12. Mid-Size Pharmaceutical Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 DAIICHI SANKYO COMPANY LIMITED
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Eisai Co., Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bausch Health Companies Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Regeneron Pharmaceuticals, Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sun Pharmaceutical Industries Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Alexion Pharmaceuticals, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mallinckrodt
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Endo Pharmaceuticals Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. US Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 3. US Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic Developments Done By Companies
Table 15. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Mid-Size Pharmaceutical Segmentation
Figure 2. North America Mid-Size Pharmaceutical Segmentation, By Country
Figure 3. North America Mid-Size Pharmaceutical Overview
Figure 4. Over-the-Counter Segment Held Largest Share by Type in North America Mid-Size Pharmaceutical Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028
Figure 8. North America Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
Figure 9. North America Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. North America Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
Figure 12. North America In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
Figure 15. North America Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
Figure 20. North America Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America: Mid-Size Pharmaceutical Market, by Key Country – Revenue (2022) (US$ Million)
Figure 26. North America: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
Figure 27. US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Growth Strategies Done by the Companies in the Market, (%)
- Alexion Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Daiichi Sankyo Company Limited
- Eisai Co., Ltd.
- Endo Pharmaceuticals Inc.
- Mallinckrodt
- Regeneron Pharmaceuticals, Inc
- Sun Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America mid-size pharmaceutical market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America mid-size pharmaceutical market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the mid-size pharmaceutical market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution